Glenmark launches generic Lacosamide Injection USP in US Market

Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually

Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies

Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments

Aurobindo Pharma receives USFDA nod for generic Tofacitinib tablets

Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval

Suven Life reports positive interim review for phase 3 Alzheimer’s therapy

Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial

Kaushik Deb elevated to Vice President at Mankind Pharma

Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth

CORONA Remedies spearheads green footprint campaign on World Environment Day

The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices

Finerenone expands promise beyond diabetic kidney disease

The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized

Wanbury FY26 PAT surges 117% to Rs. 66.1 crore

Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials

Targeting deadly drug-resistant acinetobacter infections

Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS

Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness